Element Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Element Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,111	Closed	-$217K	–	998
2018 Q4	$217K	Buy	+5,111	New	+$204K	0.01%	544
2018 Q2	–	Sell	-32,680	Closed	-$1M	–	1043
2018 Q1	$1M	Buy	+32,680	New	+$907K	0.02%	203
2017 Q4	–	Sell	-17,422	Closed	-$204K	–	174
2017 Q3	$204K	Sell	17,422 -89,800	-84%	-$520K	0.08%	36
2017 Q2	$391K	Buy	+107,222	New	+$411K	0.08%	46

Other funds holding MRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Element Capital Management's MRTX Position: Q1 2019 in Review

Element Capital Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2019, closing a stake of 5,111 shares — an estimated $217K sold.

Element Capital Management first reported a position in MRTX in Q2 2017 and held it in 4 quarters. The position peaked at $1M in Q1 2018. 159 funds tracked by Wall St. Rank hold MRTX as of Q1 2019.

Element Capital Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Element Capital Management sold 5,111 Mirati Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $217K.
Element Capital Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2017 and held it in 4 quarters.
Element Capital Management's Mirati Therapeutics, Inc. Common Stock position peaked at $1M in Q1 2018.
159 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Element Capital Management's 13F filing for Q1 2019, filed 13 May 2019.